Milwaukee area biotech ZyStor seeks more funding

Wauwatosa, Wis. ZyStor Therapeutics, Inc. will seek additional venture funding this year in advance of filing for an investigational new drug application, president and CEO Loren G. Peterson said. Peterson explained the company's plans during an informal gathering at the Innovation Monday p...

Dan Broderick Joins Prolog Ventures as Partner

...rough MHIN that Broderick developed a close rapport with Prolog's other partners -- Ilya Nykin and Brian Clevinger. After Broderick's fund invested in zystor Therapeutics, one of the most promising ventures in Prolog's portfolio, he joined Clevinger on the company's board of directors. The two also have ser...

Wisconsin VCs draw Missouri biotech firm to state

... The Milwaukee County Research Park Center. zystor will have labs at the research park. An investmen...ve from Wisconsin. Investors formed a new company, zystor Theraputics, to buy Symbiontics intellectual prope... stripped away in the liver, Broderick said, while zystor will use proteins, which are expected to survive l...

Life-sciences conference showcases capital ideas of Wisconsin

...ntatives giving presentations. Out-of-state companies included Seattle-based ultrasound developer Mirabilis Medica, lysomal storage disease researcher zystor Theraputics, which has relocated Missouri-based technology to Wisconsin, and Pennsylvania-based drug manufacturer NeuroGenomeX . Wisconsin ventu...

ZyStor receives first funding and buys theraputics for rare diseases

... Milwaukee zystor Theraputics, Inc., has received an undisclosed pie...Wisconsin investment that caught its attention. zystor expects to file an investigational new drug applic...atment for a year runs $160,000. The technology zystor bought from Symbiontics is called glycosylation in...

Milwaukee research alliance sees need for incubator

...re was a dearth of laboratory space available for laboratories to move in," said Dan Broderick, a managing director of Mason Wells. Read more about zystor relocation. For Milwaukee to compete, we need an incubator, Broderick said. Were supportive, because we plan on investing in the state of Wisconsin...

2004 in review: Editors picks

... Wisconsin investors also brought the technology of a St. Louis company, Symbiontics Inc., to Milwaukee with an $8.5 million financing round, forming zystor Theraputics to carry on its work in treating rare, fatal diseases. Read more in health technology and biotech . What's next? Tom Still, pre...

VC trends, company progress discussed at Mason Wells portfolio meeting

...e contacted the company to explore both IPO and acquisition strategies. zystor Therapeutics : A recent transplant from Missouri to Wisconsin, zystor reported that tests of its therapeutics for lysosomal storage diseases have...

ZyStor to exhibit cell disorder treatments

...kee, Wis. - Loren Peterson, president and CEO of zystor Therapeutics, Inc. is looking forward to showcasi...isease at the University of Florida . Second, zystor is doing animal studies in collaboration with St.... from commercialization. After the animal studies, zystor will have to put together an investigational drug ...

ZyStor seeks to raise $15M for clinical trials

...o raise more venture capital for clinical trials, zystor Therapeutics will be one of 30 firms presenting a...loping its response to Lysosomal Storage Diseases, zystor is targeting a class of more than 40 genetic disea... Venture Investors, is impressed with the progress zystor has made, especially given the fact that developin...